Showing results (381-390 of 1,343) with videos related to

Sort By:
Pageof 135
The Pharmacogenomics Journal|September 9, 2004
Chronic lithium treatment of B lymphoblasts from bipolar disorder patients reduces transient receptor potential channel 3 levelsS Andreopoulos, M Wasserman, K Woo, et al.
The Pharmacogenomics Journal|June 30, 2004
Polymorphism in candidate genes: implications for the risk and treatment of idiopathic Parkinson's diseaseY Gilgun-Sherki, R Djaldetti, E Melamed, et al.
The Pharmacogenomics Journal|April 28, 2004
Further evidence for a possible association between serotonin transporter gene and lithium prophylaxis in mood disordersA Serretti, P N Malitas, L Mandelli, et al.
The Pharmacogenomics Journal|April 14, 2004
Pharmacogenetics and bipolar disorderF Mamdani, I Jaitovich Groisman, M Alda, et al.
The Pharmacogenomics Journal|January 26, 2005
Cytogenetics and gene discovery in psychiatric disordersB S Pickard, J K Millar, D J Porteous, et al.
The Pharmacogenomics Journal|September 6, 2022
The genetic landscape of major drug metabolizing cytochrome P450 genes-an updated analysis of population-scale sequencing dataYitian Zhou, Volker M Lauschke
The Pharmacogenomics Journal|February 20, 2021
A systematic review and meta-analysis of genotype-based and individualized data analysis of SLCO1B1 gene and statin-induced myopathySaowalak Turongkaravee, Jiraphun Jittikoon, Thitiya Lukkunaprasit, et al.
The Pharmacogenomics Journal|June 8, 2011
Berberine and evodiamine influence serotonin transporter (5-HTT) expression via the 5-HTT-linked polymorphic regionY Hu, E A Ehli, J J Hudziak, et al.
The Pharmacogenomics Journal|June 8, 2011
Gene expression in blood is associated with risperidone response in children with autism spectrum disordersL Lit, F R Sharp, K Bertoglio, et al.
The Pharmacogenomics Journal|May 25, 2011
Polymorphism in multidrug resistance-associated protein gene 3 is associated with outcomes in childhood acute lymphoblastic leukemiaM Ansari, G Sauty, M Labuda, et al.
Pageof 135